5 Stocks to Watch: Week of 3/9/2026

We have a fantastic roster for you for the coming week,, including:

• Astronics (ATRO) — Aerospace powerhouse with 195% EPS growth and unanimous Strong Buys
• Quad/Graphics (QUAD) — Top-rated in its industry with 44% projected analyst upside
• Salesforce (CRM) — AI is rewriting its growth story
• IMAX (IMAX) — Blockbusters are back and it's cashing in
• Autodesk (ADSK) — Cloud + AI = 97% earnings growth incoming

Here's the story.

A note from our sponsors...

1- Autodesk (NASDAQ: ADSK)

Did you miss our feature story on ADSK the other day? Don’t snooze on this alert! Autodesk just beat Q4 estimates and investor confidence is surging back — with execution concerns fading and a sharp focus on sales optimization, the 3D design giant looks ready to reclaim its momentum. From architecture to manufacturing to media, its innovative digital solutions are quietly powering some of the world's most ambitious industries.

Zen Rating: Buy (B) — see full analysis

Recent Price: $254.00 — get current quote

Max 1-year forecast: $388.00

Why we're watching:

• Analyst support: Strong institutional backing with 13 Strong Buy ratings, 4 Buy ratings, and just 2 Hold ratings from 19 covering analysts signals robust conviction. See the ratings
• RBC Capital's Matthew Hedberg (a top 4% rated analyst) recently maintained his Buy rating with a $335 price target following the company's impressive Q4 results.
• Barclays' Saket Kalia (a top 6% rated analyst) maintained his Strong Buy rating with a $315 price target, expressing optimism about Autodesk's strategic positioning.
• Industry ranking context: Autodesk is currently the 21st highest-rated stock out of over 170 in the App industry, which has an Industry Rating of B.
• Zen Rating highlights: Autodesk shows exceptional earnings growth potential of 97.79% in the next year to $10.44 per share — part of why it earns an overall B or Buy rating from our Zen Ratings system.
• Component Grades: The company demonstrates exceptional strength with A grades in both Financials and Artificial Intelligence, reflecting solid financial health and strong positioning in the AI-driven design software revolution. (See all 7 Zen Component Grades here)

2- Salesforce (NYSE: CRM)

Salesforce is no longer just a CRM giant — its Agentforce AI platform is taking the enterprise world by storm, and a fresh Formula 1 partnership is putting the brand on a whole new stage. The result? Significant adoption across enterprise customers that has Wall Street buzzing with conviction.

Zen Rating: Buy (B) — see full analysis

Recent Price: $197.96 — get current quote

Max 1-year forecast: $405.00

Why we're watching:

• Analyst support: Wall Street shows strong conviction with 17 Strong Buy ratings, 8 Buy ratings, and 7 Hold ratings from 33 analysts covering the stock. See the ratings
• TD Cowen's J. Derrick Wood (a top 8% rated analyst) recently maintained his Strong Buy rating with a $250 price target following the company's Q4 earnings report.
• BMO Capital's Keith Bachman (a top 6% rated analyst) maintained his Buy rating with a $225 price target, highlighting the company's improving execution and AI-driven growth opportunities.
• Industry ranking context: Salesforce is currently the 19th highest-rated stock out of 171 in the App industry, which has an Industry Rating of B.
• Zen Rating highlights: Buy (B) stocks average +19.88%/yr, positioning Salesforce in the top 20% of stocks we track, and among quality growth opportunities in the enterprise software space.
• Component Grades: The company demonstrates balanced strength with a Sentiment grade of A, reflecting strong Wall Street optimism, alongside solid B grades in Value and Financials, and a B grade in Artificial Intelligence positioning. (See all 7 Zen Component Grades here)

A note from our sponsors...

3- Quad/Graphics (NYSE: QUAD)

Quad/Graphics just hiked its dividend by 33% and blew past Q4 earnings estimates — and while most investors overlook this marketing solutions provider, its aggressive pivot toward high-value digital services could make it the turnaround story of the year.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $6.51 — get current quote

Max 1-year forecast: $10.00

Why we're watching:

• Analyst support: Unanimous bullish outlook with 1 Strong Buy and 1 Buy rating from the 2 analysts covering the stock. See the ratings
• Rosenblatt analyst Barton Crockett (a top 17% rated analyst) maintains a Strong Buy rating with a $9.80 price target (+41.82% upside) following the company's impressive Q4 results where EPS of $0.22 beat estimates by 144%.
• Barrington Research analyst Kevin Steinke (a top 11% rated analyst) maintains a Buy rating with a $10 price target (+44.72% upside), reflecting confidence in the company's strategic transformation.
• The company reported strong Q4 results with CEO highlighting significant operational progress and solid financial performance, generating strong cash flow despite planned sales declines while gaining momentum in shifting revenue mix toward higher-value offerings.
• Industry ranking context: QUAD is currently the #1 highest-rated stock in the Specialty Business Service industry, which has an Industry Rating of C.
• Zen Rating highlights: Not only is QUAD an A (Strong Buy) rated stock according to our 115-factor quant review, but it demonstrates impressive turnaround potential with forecasted EPS growth to $1.15 (up +102% year-over-year) and strong 46.84% return on equity.
• Component Grades: The company scores B grades in Value, Safety, and Financials, demonstrating solid fundamentals with strong operating cash flow of $145.9M and improving operational efficiency. See all 7 Zen Component Grades here

4- Astronics Corp (NASDAQ: ATRO)

Astronics Corp is the company behind the power and connectivity systems inside your next flight — and after crushing Q4 earnings and trading near its 52-week high, Wall Street is betting this aerospace play still has room to run.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $76.18 — get current quote

Max 1-year forecast: $107.00

Why we're watching:

• Analyst support: ATRO enjoys unanimous bullish sentiment with 2 Strong Buy ratings from the analysts covering the stock. See the ratings
• Truist Securities' Michael Ciarmoli (a top 1% rated analyst) recently maintained his Strong Buy rating and raised his price target to $107 following the company's Q4 earnings beat, citing increased confidence in not only sustained aero operating margins but the potential for further increases to an upper teen range.
• TD Cowen analyst Gautam Khanna (a top 6% rated analyst) initiated coverage with a Strong Buy rating and $65 price target, recognizing the company's strong positioning in the aerospace recovery.
• The company recently beat Q4 EPS estimates by 2.47% while delivering revenue of $862.13M, demonstrating solid execution on both top and bottom lines with impressive 195.67% year-over-year EPS growth.
• Industry ranking context: ATRO is currently the 4th highest-rated stock in the Defense industry, which has an Industry Rating of C.
• Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr — Astronics shows exceptional potential according to our Zen Ratings system.
• Component Grades: The company earns strong B grades in Growth, Financials, Momentum, Sentiment, and Safety. That Financials score is particularly impressive, reflecting a 12.3% profit margin and strong cash flow generation. See all 7 Zen Component Grades here

5- Jazz Pharmaceuticals PLC (NASDAQ: JAZZ)

Jazz Pharmaceuticals specializes in sleep disorder and oncology therapies, with a leading focus on narcolepsy. After beating Q4 earnings and surpassing $1 billion in CBD drug sales, the company is poised for continued growth in specialty pharmaceuticals.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $188.99 — get current quote

Max 1-year forecast: $275.00

Why we're watching:

• Analyst support: Strong conviction from Wall Street with 7 Strong Buy ratings, 3 Buy ratings, and only 1 Hold from 11 analysts covering the stock. See the ratings
• Barclays analyst Etzer Darout (a top 2% rated analyst) recently initiated coverage with a Strong Buy rating and $224 price target, citing the company's compelling growth opportunity with its current pipeline and market dynamics.
• Needham analyst Ami Fadia (a top 1% rated analyst) maintains a Buy rating with a $235 price target, noting the company's expanding market presence and favorable growth outlook.
• Industry ranking context: JAZZ is currently the 3rd highest-rated stock out of 475 in the Biotech industry, which has an Industry Rating of F, making Jazz's Strong Buy rating particularly noteworthy in a challenging sector.
• Zen Rating highlights: As an A (Strong Buy) rated stock, JAZZ is in the top 5% of tickers we track based on a careful review of 115 factors proven to drive stock growth, cementing its top spot among biotech stocks with strong forecasted EPS growth for the next 3 years.
• Component Grades: Jazz scores an A in both Value and Growth, complemented by a B in Financials, reflecting strong operational fundamentals and expansion potential. See all 7 Zen Component Grades here

BONUS: Imax Corp (NYSE: IMAX)

There are serious reasons why we like IMAX better than Netflix. It just crushed Q4 expectations, fueled by a booming Chinese box office — and with Avatar: Fire and Ash on the horizon, 2026 is shaping up to be one of its biggest years yet. Behind it all is a proprietary technology and theater architecture that continues to set the gold standard for immersive entertainment worldwide.

Zen Rating: Buy (B) — see full analysis

Recent Price: $40.81 — get current quote

Max 1-year forecast: $48.00

Why we're watching:

• Analyst support: The stock enjoys broad Wall Street backing with 5 Strong Buy ratings, 3 Buy ratings, and just 1 Hold rating from 9 covering analysts. See the ratings
• JP Morgan's David Karnovsky (a top 7% rated analyst) recently maintained his Strong Buy rating with a $48 price target, noting a strong market rebound with increasing attendance rates and upcoming blockbuster releases expected to boost revenues.
• Rosenblatt's Steve Frankel (a top 6% rated analyst) maintained his Strong Buy rating with a $47 price target following the company's strong Q4 performance.
• Industry ranking context: IMAX is currently the 2nd highest-rated stock in the Entertainment industry, demonstrating exceptional positioning despite the industry's overall F rating.
• Zen Rating highlights: Buy (B) stocks represent the top 20% of stocks we track, and have historically delivered 19.88% annual returns. 
• Component Grades: The company shows balanced strength with B grades in Growth and Safety, reflecting solid fundamentals and strong growth trajectory in the recovering entertainment sector. (See all 7 Zen Component Grades here)

What to Do Next?

• 77 Best Stocks NOW! >
• See All “A” Rated Stocks with +32.52% Average Annual Return >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.